These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30130643)

  • 1. Implementing the centiloid transformation for
    Bourgeat P; Doré V; Fripp J; Ames D; Masters CL; Salvado O; Villemagne VL; Rowe CC;
    Neuroimage; 2018 Dec; 183():387-393. PubMed ID: 30130643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardized Expression of 18F-NAV4694 and 11C-PiB β-Amyloid PET Results with the Centiloid Scale.
    Rowe CC; Jones G; Doré V; Pejoska S; Margison L; Mulligan RS; Chan JG; Young K; Villemagne VL
    J Nucl Med; 2016 Aug; 57(8):1233-7. PubMed ID: 26912446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of
    Doré V; Bullich S; Rowe CC; Bourgeat P; Konate S; Sabri O; Stephens AW; Barthel H; Fripp J; Masters CL; Dinkelborg L; Salvado O; Villemagne VL; De Santi S
    Alzheimers Dement; 2019 Jun; 15(6):807-816. PubMed ID: 31101517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3.
    Bourgeat P; Doré V; Burnham SC; Benzinger T; Tosun D; Li S; Goyal M; LaMontagne P; Jin L; Rowe CC; Weiner MW; Morris JC; Masters CL; Fripp J; Villemagne VL;
    Neuroimage; 2022 Nov; 262():119527. PubMed ID: 35917917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods.
    Jovalekic A; Roé-Vellvé N; Koglin N; Quintana ML; Nelson A; Diemling M; Lilja J; Gómez-González JP; Doré V; Bourgeat P; Whittington A; Gunn R; Stephens AW; Bullich S
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3276-3289. PubMed ID: 37300571
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Rowe CC; Doré V; Jones G; Baxendale D; Mulligan RS; Bullich S; Stephens AW; De Santi S; Masters CL; Dinkelborg L; Villemagne VL
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2053-2059. PubMed ID: 28643043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-negative matrix factorisation improves Centiloid robustness in longitudinal studies.
    Bourgeat P; Doré V; Doecke J; Ames D; Masters CL; Rowe CC; Fripp J; Villemagne VL;
    Neuroimage; 2021 Feb; 226():117593. PubMed ID: 33248259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep Learning-Driven Estimation of Centiloid Scales from Amyloid PET Images with
    Yamao T; Miwa K; Kaneko Y; Takahashi N; Miyaji N; Hasegawa K; Wagatsuma K; Kamitaka Y; Ito H; Matsuda H
    Brain Sci; 2024 Apr; 14(4):. PubMed ID: 38672055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A universal neocortical mask for Centiloid quantification.
    Bourgeat P; Doré V; Rowe CC; Benzinger T; Tosun D; Goyal MS; LaMontagne P; Jin L; Weiner MW; Masters CL; Fripp J; Villemagne VL; ;
    Alzheimers Dement (Amst); 2023; 15(3):e12457. PubMed ID: 37492802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Centiloid scaling for quantification of brain amyloid with [
    Battle MR; Pillay LC; Lowe VJ; Knopman D; Kemp B; Rowe CC; Doré V; Villemagne VL; Buckley CJ
    EJNMMI Res; 2018 Dec; 8(1):107. PubMed ID: 30519791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harmonizing florbetapir and PiB PET measurements of cortical Aβ plaque burden using multiple regions-of-interest and machine learning techniques: An alternative to the Centiloid approach.
    Chen K; Ghisays V; Luo J; Chen Y; Lee W; Wu T; Reiman EM; Su Y
    Alzheimers Dement; 2024 Mar; 20(3):2165-2172. PubMed ID: 38276892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of simulated reduced injected dose on the assessment of amyloid PET scans.
    Young P; Heeman F; Axelsson J; Collij LE; Hitzel A; Sanaat A; Niñerola-Baizan A; Perissinotti A; Lubberink M; Frisoni GB; Zaidi H; Barkhof F; Farrar G; Baker S; Gispert JD; Garibotto V; Rieckmann A; Schöll M;
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):734-748. PubMed ID: 37897616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parametric imaging of dual-time window [
    Heeman F; Yaqub M; Hendriks J; Bader I; Barkhof F; Gispert JD; van Berckel BNM; Lopes Alves I; Lammertsma AA
    Neuroimage; 2021 Jul; 234():117953. PubMed ID: 33762215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of regional brain amyloid-β deposition with
    Bao YW; Wang ZJ; Guo LL; Bai GJ; Feng Y; Zhao GD
    Neuroradiology; 2024 Sep; 66(9):1537-1551. PubMed ID: 38676749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.
    Vallabhajosula S
    Semin Nucl Med; 2011 Jul; 41(4):283-99. PubMed ID: 21624562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential centiloid scale normalization techniques: comparison between hybrid PET/MRI and independently acquired MRI.
    Yamakuni R; Murakami T; Ukon N; Kakamu T; Toda W; Hattori K; Sekino H; Ishii S; Fukushima K; Matsuda H; Ugawa Y; Wakasugi N; Abe M; Ito H
    Ann Nucl Med; 2024 Oct; 38(10):835-846. PubMed ID: 38902587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data.
    Lundqvist R; Lilja J; Thomas BA; Lötjönen J; Villemagne VL; Rowe CC; Thurfjell L
    J Nucl Med; 2013 Aug; 54(8):1472-8. PubMed ID: 23740104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Software development for quantitative analysis of brain amyloid PET.
    Matsuda H; Yamao T
    Brain Behav; 2022 Mar; 12(3):e2499. PubMed ID: 35134278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale.
    Navitsky M; Joshi AD; Kennedy I; Klunk WE; Rowe CC; Wong DF; Pontecorvo MJ; Mintun MA; Devous MD
    Alzheimers Dement; 2018 Dec; 14(12):1565-1571. PubMed ID: 30006100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of PET Reconstruction on Amyloid-β Quantitation in Cross-Sectional and Longitudinal Analyses.
    Ruwanpathirana GP; Williams RC; Masters CL; Rowe CC; Johnston LA; Davey CE
    J Nucl Med; 2024 May; 65(5):781-787. PubMed ID: 38575189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.